Collaborations & Alliances
Related Searches:
Filter by:
586 - 600 of 1095 results
June 11, 2010
Patheon has signed an expanded contract manufacturing agreement with Merck.
Read More »
June 8, 2010
Hospira and Durect Corp. have entered into a licensing agreement to develop and market Durect’s Posidur (SABER-bupivacaine), a long-acting version of the anesthetic bupivacaine, currently in Phase III trials.
Read More »
June 8, 2010
TransTech Pharma and Forest Laboratories have entered into a license agreement for the development and commercialization of small molecule compounds discovered by TransTech.
Read More »
June 7, 2010
Immunovaccine, Inc. has signed a collaborative research agreement with Vaxil BioTherapeutics to explore the efficacy of Vaxil's cancer antigens in Immunovaccine's DepoVax vaccine enhancement platform.
Read More »
June 4, 2010
Ascenta Therapeutics has signed a global collaboration and licensing agreement with Sanofi-Aventis for several early-stage drug candidates being investigated for their potential to restore tumor cell apoptosis.
Read More »
May 27, 2010
iMANY and Alliance Life Sciences Consulting Group (ALSCG) have entered a strategic partnership to provide contracting solutions for life sciences firms.
Read More »
May 24, 2010
Shimadzu and bioMerieux have entered into a partnership to commercialize a mass spectrometry system for bacterial identification in microbiology labs.
Read More »
May 21, 2010
Ablynx and Pfizer have extended their research collaboration and license agreement to discover and develop Nanobody-based therapeutics against tumor necrosis factor alpha (TNF-alpha), for another year.
Read More »
May 19, 2010
Evotec AG has advanced a compound in its strategic alliance with Boehringer Ingelheim into Phase I clinical studies.
Read More »
May 18, 2010
Columbia Laboratories, Inc. has renewed its license and supply agreement with Merck Serono for Crinone (progesterone gel) for an additional five years.
Read More »
May 10, 2010
Evotec AG has entered into a multi-year integrated drug discovery alliance with Genentech to discover novel small molecule therapeutics.
Read More »
May 10, 2010
Tekmira Pharmaceuticals Corp. has entered into a multi-year target validation agreement with Bristol-Myers Squibb.
Read More »
May 6, 2010
Merck has restructured its co-development and commercialization agreement with Ariad Pharmaceuticals, Inc., obtaining an exclusive license to ridaforolimus, an investigational, oral mTOR inhibitor in development for the treatment of multiple types of can
Read More »
May 5, 2010
Boehringer Ingelheim and Micromet, Inc. have entered into a collaboration agreement for the research, development and commercialization of a new BiTE antibody for the treatment of multiple myeloma.
Read More »
May 4, 2010
Vetter, a provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, have signed a preferred partnership agreement.
Read More »
586 - 600 of 1095 results
